Aurora Cannabis, an Edmonton, Alberta-based cannabis producer, reported fiscal third-quarter revenue of 75 million Canadian dollars ($56 million) – up more than 365% from a year ago.
The company’s net loss grew to CA$158.3 million – up from $19.2 million in the year-ago quarter.
The boost in sales was fueled by growth across its key markets, the company said in a news release.
Revenue attributable to Canada’s adult-use market grew 37% from the previous quarter to $29.6 million. Medical cannabis sales grew to $29 million, up 12% from the previous quarter.
The surging red ink reflects the company’s obligation to revalue the convertible debt it carries on its balance sheet, resulting in losses of CA$101.5 million.
Aurora trades on the New York Stock Exchange under the ticker symbol ACB.
For more analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.